Cargando…
The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI
BACKGROUND: Aortic stenosis (AS) can cause acquired von Willebrand syndrome (AVWS) and valve replacement has been shown to lead to von Willebrand factor (vWF) recovery. The aim of the current study was to investigate the prevalence of AVWS in different severe AS phenotypes and its course after trans...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681694/ https://www.ncbi.nlm.nih.gov/pubmed/35838799 http://dx.doi.org/10.1007/s00392-022-02047-6 |
_version_ | 1784834677388869632 |
---|---|
author | Roth, Nastasia Heidel, Carolin Xu, Congde Hubauer, Ute Wallner, Stefan Meindl, Christine Holzamer, Andreas Hilker, Michael Creutzenberg, Marcus Sossalla, Samuel Maier, Lars Jungbauer, Carsten Debl, Kurt |
author_facet | Roth, Nastasia Heidel, Carolin Xu, Congde Hubauer, Ute Wallner, Stefan Meindl, Christine Holzamer, Andreas Hilker, Michael Creutzenberg, Marcus Sossalla, Samuel Maier, Lars Jungbauer, Carsten Debl, Kurt |
author_sort | Roth, Nastasia |
collection | PubMed |
description | BACKGROUND: Aortic stenosis (AS) can cause acquired von Willebrand syndrome (AVWS) and valve replacement has been shown to lead to von Willebrand factor (vWF) recovery. The aim of the current study was to investigate the prevalence of AVWS in different severe AS phenotypes and its course after transcatheter aortic valve implantation (TAVI). METHODS: 143 patients with severe AS undergoing TAVI were included in the study. vWF function was assessed at baseline, 6 and 24 h after TAVI. AVWS was defined as a reduced vWF:Ac/Ag ratio ≤ 0.7. Phenotypes were classified by tricuspid (TAV) and bicuspid (BAV) valve morphology, mean transvalvular gradient (P(mean)), stroke volume index (SVI), ejection fraction (EF) and indexed effective orifice area (iEOA). RESULTS: AVWS was present in 36 (25.2%) patients before TAVI. vWF:Ac/Ag ratio was significantly lower in high gradient compared to low-gradient severe AS [0.78 (IQR 0.67–0.86) vs. 0.83 (IQR 0.74–0.93), p < 0.05] and in patients with BAV compared to TAV [0.70 (IQR 0.63–0.78) vs. 0.81 (IQR 0.71–0.89), p < 0.05]. Normalization of vWF:Ac/Ag ratio was achieved in 61% patients 24 h after TAVI. As in the overall study cohort, vWF:Ac/Ag ratio increased significantly in all severe AS subgroups 6 h after TAVI (each p < 0.05). Regarding binary logistic regression analysis, BAV was the only significant predictor for AVWS. CONCLUSIONS: BAV morphology is a strong predictor for AVWS in severe AS. TAVI restores vWF function in most patients with severe AS independently of AS phenotype and valve morphology. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9681694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-96816942022-11-24 The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI Roth, Nastasia Heidel, Carolin Xu, Congde Hubauer, Ute Wallner, Stefan Meindl, Christine Holzamer, Andreas Hilker, Michael Creutzenberg, Marcus Sossalla, Samuel Maier, Lars Jungbauer, Carsten Debl, Kurt Clin Res Cardiol Original Paper BACKGROUND: Aortic stenosis (AS) can cause acquired von Willebrand syndrome (AVWS) and valve replacement has been shown to lead to von Willebrand factor (vWF) recovery. The aim of the current study was to investigate the prevalence of AVWS in different severe AS phenotypes and its course after transcatheter aortic valve implantation (TAVI). METHODS: 143 patients with severe AS undergoing TAVI were included in the study. vWF function was assessed at baseline, 6 and 24 h after TAVI. AVWS was defined as a reduced vWF:Ac/Ag ratio ≤ 0.7. Phenotypes were classified by tricuspid (TAV) and bicuspid (BAV) valve morphology, mean transvalvular gradient (P(mean)), stroke volume index (SVI), ejection fraction (EF) and indexed effective orifice area (iEOA). RESULTS: AVWS was present in 36 (25.2%) patients before TAVI. vWF:Ac/Ag ratio was significantly lower in high gradient compared to low-gradient severe AS [0.78 (IQR 0.67–0.86) vs. 0.83 (IQR 0.74–0.93), p < 0.05] and in patients with BAV compared to TAV [0.70 (IQR 0.63–0.78) vs. 0.81 (IQR 0.71–0.89), p < 0.05]. Normalization of vWF:Ac/Ag ratio was achieved in 61% patients 24 h after TAVI. As in the overall study cohort, vWF:Ac/Ag ratio increased significantly in all severe AS subgroups 6 h after TAVI (each p < 0.05). Regarding binary logistic regression analysis, BAV was the only significant predictor for AVWS. CONCLUSIONS: BAV morphology is a strong predictor for AVWS in severe AS. TAVI restores vWF function in most patients with severe AS independently of AS phenotype and valve morphology. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-07-15 2022 /pmc/articles/PMC9681694/ /pubmed/35838799 http://dx.doi.org/10.1007/s00392-022-02047-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Roth, Nastasia Heidel, Carolin Xu, Congde Hubauer, Ute Wallner, Stefan Meindl, Christine Holzamer, Andreas Hilker, Michael Creutzenberg, Marcus Sossalla, Samuel Maier, Lars Jungbauer, Carsten Debl, Kurt The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI |
title | The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI |
title_full | The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI |
title_fullStr | The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI |
title_full_unstemmed | The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI |
title_short | The impact of bicuspid aortic valve morphology on von Willebrand factor function in patients with severe aortic stenosis and its change after TAVI |
title_sort | impact of bicuspid aortic valve morphology on von willebrand factor function in patients with severe aortic stenosis and its change after tavi |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681694/ https://www.ncbi.nlm.nih.gov/pubmed/35838799 http://dx.doi.org/10.1007/s00392-022-02047-6 |
work_keys_str_mv | AT rothnastasia theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT heidelcarolin theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT xucongde theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT hubauerute theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT wallnerstefan theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT meindlchristine theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT holzamerandreas theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT hilkermichael theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT creutzenbergmarcus theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT sossallasamuel theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT maierlars theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT jungbauercarsten theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT deblkurt theimpactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT rothnastasia impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT heidelcarolin impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT xucongde impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT hubauerute impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT wallnerstefan impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT meindlchristine impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT holzamerandreas impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT hilkermichael impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT creutzenbergmarcus impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT sossallasamuel impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT maierlars impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT jungbauercarsten impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi AT deblkurt impactofbicuspidaorticvalvemorphologyonvonwillebrandfactorfunctioninpatientswithsevereaorticstenosisanditschangeaftertavi |